Amarin Corp Plc (AMRN)

[rafunrafun]

Scripts for week ending September 17, 2021 - post Labor Day 'bounce'

Overall drug TRx are +10.0% w/w

Vascepa
TRx 82,100; +8.6% (+6,529) w/w; -11.0% y/y
NRx 37,120; +13.7% (+4,480) w/w; -13.8% y/y
Ref 44,979; +4.8% (+2,049) w/w; -8.5% y/y

Lovaza (Generic & Brand)
TRx 64,265; +9.0% (+5,279) w/w; -0.5% y/y
NRx 31,407; +14.3% (+3,921) w/w; -3.4% y/y
Ref 32,859; +4.4% (+1,376) w/w; +2.3% y/y

Generic Vascepa
TRx 19,263; +11.8% (+2,063) w/w; As % of total V: 19.0%
NRx 10,841; +14.6% (+1,381) w/w; As % of total V: 22.6%
Ref 8,422; +8.4% (+655) w/w; As % of total V: 15.8%

Generic Vascepa by Manufacturer
Hikma - TRx 12,834 (+1,286); Generic share 66.6%; Total V share 12.7%
Reddy - TRx 6,430 (+751); Generic share 33.4%; Total V share 6.3%

TRx Vascepa + Generic Vascepa: 101,363 (+8,565)